Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect of ENZO BIOCHEM INC from 31 Jul 2018 to 31 Oct 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
ENZO BIOCHEM INC quarterly and annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD history and change rate from 31 Jul 2018 to 31 Oct 2024.
  • ENZO BIOCHEM INC Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 31 Oct 2024 was $4,636,000, a 67% increase year-over-year.
  • ENZO BIOCHEM INC annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was $31,002,000, a 151% decline from 2023.
  • ENZO BIOCHEM INC annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $60,770,000, a 630% increase from 2022.
  • ENZO BIOCHEM INC annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $8,329,000.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

ENZO BIOCHEM INC Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $4,636,000 +$9,530,000 +67% 01 Aug 2024 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q3 2023 $14,166,000 -$4,698,000 -50% 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q1
Q3 2022 $9,468,000 -$2,300,000 -32% 01 Aug 2022 31 Oct 2022 10-Q 15 Dec 2023 2024 Q1
Q3 2021 $7,168,000 -$5,217,000 -267% 01 Aug 2021 31 Oct 2021 10-Q 12 Dec 2022 2023 Q1
Q3 2020 $1,951,000 +$552,000 +22% 01 Aug 2020 31 Oct 2020 10-Q 15 Dec 2021 2022 Q1
Q3 2019 $2,503,000 01 Aug 2019 31 Oct 2019 10-Q 11 Dec 2020 2021 Q1

ENZO BIOCHEM INC Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $31,002,000 -$91,772,000 -151% 01 Aug 2023 31 Jul 2024 10-K 29 Oct 2024 2024 FY
2023 $60,770,000 +$52,441,000 +630% 01 Aug 2022 31 Jul 2023 10-K 29 Oct 2024 2024 FY
2022 $8,329,000 +$42,670,000 01 Aug 2021 31 Jul 2022 10-K 03 Nov 2023 2023 FY
2021 $34,341,000 -$22,060,000 -180% 01 Aug 2020 31 Jul 2021 10-K 14 Oct 2022 2022 FY
2020 $12,281,000 -$13,136,000 -1536% 01 Aug 2019 31 Jul 2020 10-K 14 Oct 2022 2022 FY
2019 $855,000 +$4,981,000 01 Aug 2018 31 Jul 2019 10-K 12 Oct 2021 2021 FY
2018 $4,126,000 01 Aug 2017 31 Jul 2018 10-K 19 Oct 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.